Biohaven Tumbles After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump

cafead

Administrator
Staff member
  • cafead   May 29, 2024 at 09:42: PM
via Biohaven (BHVN) stock tumbled Wednesday after the company's experimental protein-degrading drug — which could be used to treat a myriad of immune-related diseases — lagged investor expectations.

article source